| Budget year | Amount | Funding source |
| 2006-2013 | 99,506.00 € | Heinrich-Heine-Univ. Düsseldorf/ DFG- Graduiertenkolleg 1427 (Roos) |
| 2007-2011 | 635,150.00 € | DGUV/ IRRE 1 |
| 2007-2011 | 621,108.00 € | BMBF/ ToxGenom |
| 2007-2011 | 67,000.00 € | CEFIC, FKE/ Phytoöstrogene |
| 2007-2012 | 31,000.00 € | Springer-Verlag/ Toxikologische Forschung |
| 2008-2011 | 854,850.00 € | EU/ CancerSys |
| 2006 – 2013 | 96,390.00 € | Heinrich-Heine-Univ. Düsseldorf/ DFG-Graduiertenkolleg 1427 (Degen) |
| 2008-2012 | 8,000.00 € | BMBF/ “Sugar grant“ Regneration/HepatoSys |
| 2008-2012 | 1,825.00 € | Ruhr-Universität Bochum/ Cytochrome |
| 2008-2017 | 261,000.00 € | Springer-Verlag/Archives of Toxicology |
| 2008-2012 | 406,400.00 € | BMBF/ Oncoprofile |
| 2008-2013 | 977,000.00 € | EU/ ESNATS |
| 2008-2013 | 790,234.00 € | EU/ Aufstockung ESNATS |
| 2009-2011 | 33,585.00 € | DFG/ Kooperation Chile |
| 2009-2011 | 42,000.00 € | DAAD/ CONICYT (Chile Programm) Doktorandenstipendium € 14.000,-/Jahr |
| 2009-2011 | 500,000.00 € | BMBF/ LiverStemCell |
| 2009-2011 | 600,000.00 € | BMBF/ Micro Fluidic |
| 2009 – 2012 | 370,863.00 € | EU/Land NRW/ Mykotoxine II |
| 2009-2012 | 241,848.00 € | BMBF/ Liver fibrosis |
| 2010-2012 | 128,400.00 € | DFG/ WISP1 |
| 2010-2015 | 1,745,645.00 € | BMBF/ Virtual Liver |
| 2011 – 2012 | 10,000.00 € | Gedek-Stiftung |
| 2011 – 2012 | 8,300.00 € | DFG/ Internationale Kooperation Türkei |
| 2011-2014 | 395,499.00 € | BMBF/ Network Formation Assay |
| 2011-2015 | 561,048.00 € | EU/ NOTOX |
| 2011-2015 | 618,317.00 € | EU/ DETECTIVE |
| 2011-2016 | 881,904.60 € | DGUV/ IRRE 2 |
| 2011-2016 | 19,590.00 € | Lead Discovery Center/LDC |
| 2012 | 5,000.00 € | Universität Wageningen/ Occupational Toxicology 2012 |
| 2012 – 2013 | 9,000.00 € | Eurotox |
| 2012 – 2015 | 45,000.00 € | DAAD /South Asia Program |
| 2012 –2015 | 1,725.00 € | DAAD/ South Asia Program,study and research subsidy |
| 2012-2015 | 275,750.00 € | EU/ Body-on-Chip |
| 2012-2017 | 452,952.00 € | BMBF/ DEEP |
| 2013-2014 | 10,000.00 € | Gedek-Stiftung/ Citrinin |
| 2013-2015 | 284,325.00 € | BMBF/ Verbundprojekt LivSys |
| 2013-2017 | 90,000.00 € | INRIA/ iFlow |
| 2014 | 3,320.00 € | Universität Wageningen/ Occupational Toxicology 2014 |
| 2014-2015 | 134,209.00 € | BMBF/ Verbundprojekt SysDT |
| 2014-2017 | 366,329.00 € | BMBF/ LCI-MEA (Life Cell Imaging –
Micro Electrode Array) |
| 2014-2017 | 493,770.00 € | BMBF/ Verbundprojekt Lebersimulator |
| 2014-2017 | 10,000.00 € | ANKÜR/ Boren II |
| 2016-2021 | 930,375.00 € | EU/ EUToxRisk21 |
| 2016 | 1,485.00 € | Universität Wageningen/ Occupational Toxicology 2016 |
| 2016-2019 | 168,493.80 € | Fachagentur Nachwachsende Rohstoffe e.V. (FNR)/ GesundHolz |
| 2016-2018 | 400,000.00 € | DGUV/ IRRE IV |
| 2016-2019 | 324,400.00 € | DFG/ EDI3 |
| 2016-2019 | 225,300.00 € | DFG/ WISP1-II |
| 2016-2019 | 134,710.00 € | BMBF/ InnoSysTox |
| 2016-2019 | 250,800.00 € | BMBF/ DILI |
| 2016-2021 | 1,276,732.00 € | BMBF/ LiSym (Ghallab) |
| 2016-2021 | 2,212,235.00 € | BMBF/ LiSym (Vartak) |
| 2016-2021 | 2,802,501.00 € | BMBF/ LiSym (Pillar II/III) |
| 2017-2020 | 345,602.00 € | BMBF/ LivSys Transfer |
| 2017-2020 | 246,765.00 € | BMBF/ SysDT Transfer |
| 2017-2020 | 281,118.90 € | DLR/ StemCellNet |
| 2017- 2018 | 14,824.00 € | DAAD/ Norwegen |
| 2017-2022 | 350,250.00 € | EU/ IMI Trans QST |
| 2017-2022 | 1,076,100.00 € | Land NRW/ Drug Discovery Hub |
| 2017-2020 | 263.702,00 € | DFG/IL-15 |
| 2017-2021 | 186,702.00 $ | Thomas Jefferson University/Multiscale Modeling |
| 2018-2021 | 350,910.00 € | BMBF/SteatoTox |
| 2018-2020 | 76,750.00 € | DFG/NK-DILI-ILC2 |
| 2018-2019 | 771,150.00 € | DFG/SKLM |
| 2018-2019 | 3,000.00 € | IPB Halle/Bioactive Compounds |
| 2020-2022 | 859,650.00 € | DFG/SKLM |
| 2020-2023 | 230,000.00 € | Deutsche Krebshilfe/HER2+ |
| 2020-2024 | 154,000.00 € | BMBF/InnoSysTox-Moving |
| 2021 | 18,000.00 € | BfR |
| 2021-2024 | 477,300.00 € | DFG/NAFLD-NASH-HCC |
| 2021-2024 | 1,056,955.00 € | BMBF/LiSyM-Krebs |
| 2021-2023 | 256,385.36 € | BMBF/SteatoTox-2 |
| 2021-2024 | 276,626.00 € | DFG/LPA bei Eierstockkrebs |
| 2023-2026 | 377,00.00 € | DFG/APAP-Hepatotoxizität |
| 2023-2026 | 983,250.00 € | DFG/SKLM |
